AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,143,355 | +129.5% | 714,578 | +111.8% | 0.00% | +100.0% |
Q2 2023 | $15,749,472 | +94.7% | 337,320 | +59.5% | 0.00% | +100.0% |
Q1 2023 | $8,091,000 | +80439.5% | 211,468 | +15.4% | 0.00% | 0.0% |
Q4 2022 | $10,046 | -99.9% | 183,315 | -22.2% | 0.00% | 0.0% |
Q3 2022 | $8,020,000 | +261.4% | 235,529 | +0.3% | 0.00% | – |
Q2 2022 | $2,219,000 | +240.9% | 234,827 | +412.0% | 0.00% | – |
Q1 2022 | $651,000 | -35.6% | 45,867 | -4.1% | 0.00% | – |
Q4 2021 | $1,011,000 | -7.3% | 47,824 | -2.1% | 0.00% | – |
Q3 2021 | $1,091,000 | -13.8% | 48,830 | -4.2% | 0.00% | – |
Q2 2021 | $1,265,000 | -9.3% | 50,969 | +6.1% | 0.00% | – |
Q1 2021 | $1,394,000 | +16.1% | 48,036 | +3.2% | 0.00% | – |
Q4 2020 | $1,201,000 | -34.2% | 46,545 | -20.0% | 0.00% | – |
Q3 2020 | $1,826,000 | +15.6% | 58,184 | -8.3% | 0.00% | – |
Q2 2020 | $1,580,000 | +45.5% | 63,421 | +23.8% | 0.00% | – |
Q1 2020 | $1,086,000 | -53.7% | 51,249 | -51.5% | 0.00% | – |
Q4 2019 | $2,347,000 | +22.8% | 105,730 | +25.9% | 0.00% | – |
Q3 2019 | $1,911,000 | – | 83,967 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |